Literature DB >> 26660164

Association of IL28B rs8099917 genotype and female sex with spontaneous clearance of hepatitis C virus infection: a Japanese cross-sectional study.

Hiroaki Ikezaki1,2, Norihiro Furusyo3, Satoshi Hiramine4, Kazuya Ura4, Fujiko Mitsumoto-Kaseida4, Koji Takayama4, Motohiro Shimizu4, Kazuhiro Toyoda4, Eiichi Ogawa4, Mosaburo Kainuma4, Masayuki Murata4, Jun Hayashi5.   

Abstract

Hepatitis C virus (HCV) infection is a serious global health problem. Previous studies have suggested that the interleukin 28B (IL28B) rs8099917 genotype is related to spontaneous clearance of HCV in Caucasian populations. Our objective was to investigate the association of the IL28B rs8099917 genotype with spontaneous clearance of HCV by community-dwelling Japanese. A cross-sectional community-based population study of 993 Japanese residents was conducted. Based on anti-HCV antibody and HCV RNA levels, 50 subjects were assigned to the spontaneous-clearance group, 155 to the chronic-infection group, and 788 to the control group. Logistic regression analysis was done to examine the roles of the IL28B rs8099917 genotype and sex. To analyze the interactions between these factors, an "IL28B rs809991 genotype × sex" interaction term was included in the multivariate analysis. Significantly more subjects in the spontaneous-clearance group than in the chronic-infection group had the favorable IL28B rs8099917 genotype and were female. Multivariate logistic regression analysis extracted the favorable IL28B rs8099917 TT genotype (odds ratio [OR] 9.39; 95% confidence interval [CI], 2.16-40.83, P = 0.003) and female sex (OR, 2.27; 95% CI, 1.16-4.45, P = 0.017) as factors contributing to the spontaneous clearance of HCV. No significant interaction was found between the IL28B rs8099917 genotype and sex (P for interaction = 0.428). Both the favorable IL28B rs8099917 genotype and female sex were associated with the spontaneous clearance of HCV in this Japanese population.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26660164     DOI: 10.1007/s00705-015-2703-9

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  5 in total

1.  Delayed Viral Clearance after 6-Week Treatment with Peginterferon Plus Ribavirin in a Patient with Chronic Hepatitis C Virus Genotype 1b.

Authors:  Akira Sato; Toshiya Ishii; Kayo Adachi; Hideaki Takahashi; Fumiaki Sano; Nobuyuki Matsumoto
Journal:  Case Rep Gastroenterol       Date:  2016-08-09

2.  Polymorphisms in the Th17 cell-related RORC gene are associated with spontaneous clearance of HCV in Chinese women.

Authors:  Zhe Xie; Yuantao Li; Lu Long; Hua Liang; Weiping Cai; Tao Shen
Journal:  BMC Infect Dis       Date:  2018-06-04       Impact factor: 3.090

3.  Kyushu and Okinawa Population Study (KOPS): a large prospective cohort study in Japan.

Authors:  Hiroaki Ikezaki; Norihiro Furusyo; Ryoko Nakashima; Makiko Umemoto; Ken Yamamoto; Yuji Matsumoto; Azusa Ohta; Sho Yamasaki; Satoshi Hiramine; Koji Takayama; Eiichi Ogawa; Kazuhiro Toyoda; Masayuki Murata; Nobuyuki Shimono; Jun Hayashi
Journal:  BMJ Open       Date:  2021-12-21       Impact factor: 2.692

4.  Molecular Epidemiological Characteristics and Risk Factors for Acquiring HBV Among Li Ethnic in Baisha County, Hainan Island-Subgenotype D3 Was First Discovered in China.

Authors:  Ru Xu; Dandan Song; Min Wang; Jieting Huang; Qiao Liao; Zhengang Shan; Xia Rong; Yongshui Fu
Journal:  Front Microbiol       Date:  2022-02-07       Impact factor: 5.640

5.  A Multiancestry Sex-Stratified Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.

Authors:  Candelaria Vergara; Ana Valencia; Chloe L Thio; James J Goedert; Alessandra Mangia; Valeria Piazzolla; Eric Johnson; Alex H Kral; Thomas R O'Brien; Shruti H Mehta; Gregory D Kirk; Arthur Y Kim; Georg M Lauer; Raymond T Chung; Andrea L Cox; Marion G Peters; Salim I Khakoo; Laurent Alric; Matthew E Cramp; Sharyne M Donfield; Brian R Edlin; Michael P Busch; Graeme Alexander; Hugo R Rosen; Edward L Murphy; Genevieve L Wojcik; Margaret A Taub; David L Thomas; Priya Duggal
Journal:  J Infect Dis       Date:  2021-06-15       Impact factor: 5.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.